- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: 5t4.
Displaying page 1 of 1.
EudraCT Number: 2010-023230-22 | Sponsor Protocol Number: 2010/VCC/0049 | Start Date*: 2011-04-12 | |||||||||||
Sponsor Name:Velindre NHS Trust | |||||||||||||
Full Title: A phase II trial to assess the safety, immunological activity of Trovax plus Pemetrexed/ Cisplatin in patients with malignant pleural mesothelioma. | |||||||||||||
Medical condition: The study is for patients with malignant mesothelioma of the lung lining(called pleura). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005639-26 | Sponsor Protocol Number: EFC10528 | Start Date*: 2008-04-21 | |||||||||||
Sponsor Name:Oxford BioMedica | |||||||||||||
Full Title: A Multicenter, Double Blind, Placebo controlled, Randomized study of TroVax vs Placebo in the First Line treatment of Patients with Metastatic Colorectal Cancer receiving Chemo-based Therapy. | |||||||||||||
Medical condition: Metastatic Colorectal Adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000753-22 | Sponsor Protocol Number: TV2/003/06 | Start Date*: 2006-05-04 |
Sponsor Name:Oxford MioMedica UK Ltd. | ||
Full Title: A phase I/II feasability trial to assess the safety, immunological activity and efficacy of TroVax plus interferon alpha in patients with advanced or metastatic renal cell cancer. | ||
Medical condition: Advanced or Metastatic Renal Cell Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001992-22 | Sponsor Protocol Number: ADVANCE | Start Date*: 2018-06-12 | ||||||||||||||||||||||||||
Sponsor Name:University of Oxford | ||||||||||||||||||||||||||||
Full Title: Phase II open label randomised safety and efficacy study of the viral vectored ChAd-MVA 5T4 vaccine in combination with PD-1 checkpoint blockade in low- or intermediate-risk localized or locally ad... | ||||||||||||||||||||||||||||
Medical condition: Low- and intermediate-risk prostate cancer and advanced metastatic prostate cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-005660-86 | Sponsor Protocol Number: 06_DOG03_107 | Start Date*: 2006-07-19 |
Sponsor Name:Christie Hospital NHS Trust | ||
Full Title: A Phase II, open label, single arm study to evaluate Ticilimumab in Advanced Gastric/Oesophageal Adenocarcinoma | ||
Medical condition: Advanced Gastric/Oesophageal Adenocarcinoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001836-44 | Sponsor Protocol Number: UCL/11/0119 | Start Date*: 2012-06-11 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A Phase II Trial to Assess the Activity of TroVax® (MVA-5T4) Versus Placebo in Patients with Relapsed Asymptomatic Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. | |||||||||||||
Medical condition: Patients with relapsed asymptomatic epithelial ovarian, fallopian tube or primary peritoneal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001246-13 | Sponsor Protocol Number: TV3/001/06 | Start Date*: 2007-01-22 |
Sponsor Name:Oxford BioMedica UK Ltd. | ||
Full Title: Estudio internacional, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos, para investigar si Trovax, añadido al tratamiento estándar de primera linea, prolonga la supervivenci... | ||
Medical condition: Locally advanced or metastatic renal clear cell adenocarcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) DE (Prematurely Ended) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024380-41 | Sponsor Protocol Number: SPON868-10 | Start Date*: 2011-08-25 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: A pilot study to assess the effect of regulatory T-cell depletion on 5T4-containing MVA(TroVax®)vaccination in patients with inoperable metastatic colorectal cancer | |||||||||||||
Medical condition: Inoperable metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.